Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma

Cancer Research and Treatment

Volumn 46, Issue 4, 2014, Pages 348-357

  Yu, Jeong Il ^a   Yoon, Sang Min ^b   Park, Hee Chul ^a   Kim, Jong Hoon ^b   Kim, Tae Hyun ^c   Park, Joong Won ^c   Seong, Jinsil ^d   Lee, Ik Jae ^d   Jang, Hong Seok ^e   Kay, Chul Seung ^e   Kim, Chul Yong ^f   Chie, Eui Kyu ^g   Kim, Jin Hee ^h   Kim, Mi Sook ⁱ   Choi, Young Min ^j  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

^f Korea University College of Medicine   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

^h Dongsan Medical Center   (South Korea)

ⁱ Korea Institute of Radiation and Medical Science   (South Korea)

^j Dong A University College of Medicine   (South Korea)

more..

Author keywords

Hepatocellular carcinoma; Multicenter study; Portal vein; Radiotherapy; Validation

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PORTAL VEIN TUMOR THROMBOSIS; PROGNOSTIC INDEX; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TRANSCATHETER ARTERIAL CHEMOINFUSION; TUMOR THROMBUS;

EID: 84907922760     PISSN: 1598-2998     EISSN: 2005-9256     Source Type: Journal    
DOI: 10.4143/crt.2013.142     Document Type: Article

References (25)

1. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28: 751-5.
2. Carr BI, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int. 2010;4:396-405.
3. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-7.
4. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38:207-15.
5. Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer. 2002;94:1760-9.
6. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-38.
7. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer. 1985;56:918-28.
8. Katamura Y, Aikata H, Takaki S, Azakami T, Kawaoka T, Waki K, et al. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J Gastroenterol. 2009;44:492-502.
9. Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2012;118:4725-36.
10. Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys. 2012;82: 2004-11.
11. Yu JI, Park HC, Lim DH, Park W, Yoo BC, Paik SW, et al. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy. J Korean Med Sci. 2011;26:1014-22.
12. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52-60.
13. Akaike H. A new look at statistical model identification. IEEE Trans Automat Contr. 1974;19:716-23.
14. Gerds TA, Schumacher M. Efron-type measures of prediction error for survival analysis. Biometrics. 2007;63:1283-7.
15. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92-105.
16. Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford). 2003;5:243-50.
17. Inarrairaegui M, Thurston KG, Bilbao JI, D'Avola D, Rodriguez M, Arbizu J, et al. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2010;21:1205-12.
18. Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, et al. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma. Int J Clin Oncol. 2011;16:221-9.
19. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-2.
20. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25-34.
21. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-90.
22. Burgmans MC, Irani FG, Chan WY, Teo TK, Kao YH, Goh AS, et al. Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2012;35:1519-23.
23. Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 2005;61:432-43.
24. Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer. 2005;10 3:2419-26.
25. Meng MB, Cui YL, Lu Y, She B, Chen Y, Guan YS, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol. 2009;92:184-94.